Pioglitazone-d4 (major)

Pioglitazone-d4 is a labeled thiazolidinedione, which activates PPARγ and to a lesser extent PPARα. Studies show that Pioglitazone-d4 increases splanchnic and peripheral glucose uptake in NIIDM. It is known that Pioglitazone-d4 modulates insulin-sensitive genes which control glucose and lipid metabolism in a variety of tissues such as muscle cells, adipose tissue and the liver. Alternate studies show that Pioglitazone-d4 activates Akt, while upregulating cPLA2 and Cox-2. Pioglitazone-d4 is effective in interfering with androgen binding on aromatase in human granulosa cells, which inhibits estrogen synthesis. Specification: ≥97% Molecular Formula: C19H16D4N2O3S Molecular Weight: 360.46 PubChem CID: 25235566 Isomeric SMILES: [2H]C([2H])(C1=NC=C(C=C1)CC)C([2H])([2H])OC2=CC=C(C=C2)CC3C(=O)NC(=O)S3 Related Documents: https://ald-pub-files.oss-cn-shanghai.aliyuncs.com/aladdinsci/pdp/sds/1/P334350-SCI_30d31df0c56e817e7b8098e278e15095.pdf

UPC:

51183703

Condition:

New

Weight:

0.96 Ounces

HazmatClass:

No

Quantity:

1

Unit of Measurement:

EA

WeightUOM:

LB

MPN:

P334350-1mg

CAS:

1134163-31-7

Product Size:

1mg

Hazard Statement Codes:

H319

Precautionary Statement Codes:

P264:P280